A Class in Session: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas

In this on-demand webcast, Julie M. Vose, MD, MBA; Brad S. Kahl, MD; and John P. Leonard, MD, review the current treatment paradigm for B-cell lymphomas, including key updates from ASH 2021.

Julie M. Vose, MD, MBA
Program Director Brad S. Kahl, MD John P. Leonard, MD Physicians: maximum of 2.25 AMA PRA Category 1 Credits™ Released: February 7, 2022 Expired: No longer available for credit

Treatment options have grown increasingly complex for patients with follicular lymphoma. In this commentary, I share how I approach individualizing and sequencing therapy for patients with newly diagnosed and relapsed/refractory disease.

John P. Leonard, MD Released: November 1, 2021

How are you managing patients with mantle cell lymphoma? Read this commentary for my approach.

Brad S. Kahl, MD Released: November 12, 2021

Now that ibrutinib and zanubrutinib are both approved by the FDA in the relapsed/refractory setting for marginal zone lymphoma, where do we sequence and how do we choose between these BTK inhibitors? Read this commentary for my approach.

John P. Leonard, MD Released: November 2, 2021

How are you managing patients with diffuse large B-cell lymphoma? Read this commentary for my approach.

Julie M. Vose, MD, MBA Released: December 1, 2021

How are you managing patients with EBV-associated posttransplant lymphoproliferative disease? Read this commentary for my approach.

Julie M. Vose, MD, MBA Released: December 6, 2021

Download this slideset from a live satellite symposium at ASH 2021 on current and emerging treatment options for patients with follicular lymphoma.

John P. Leonard, MD Released: December 15, 2021

Download this slideset from a live satellite symposium at ASH 2021 on current and emerging treatment options for patients with marginal zone lymphoma and mantle cell lymphoma.

Brad S. Kahl, MD Released: December 16, 2021

Download this slideset from a live satellite symposium at ASH 2021 on current and emerging treatment options for patients with marginal zone lymphoma and mantle cell lymphoma.

Julie M. Vose, MD, MBA Released: December 16, 2021

Download this slideset from a live satellite symposium at ASH 2021 on current and emerging treatment options for patients with EBV-associated post-transplant lymphoproliferative disorders.

Julie M. Vose, MD, MBA Released: December 16, 2021

Gain key clinical insights fast, with this short slideset from CCO on key considerations for optimal treatment of B-cell lymphomas.

Brad S. Kahl, MD John P. Leonard, MD Julie M. Vose, MD, MBA Released: January 4, 2022

Download this online resource developed to serve as a helpful guide for healthcare professionals on BCL-2 targeted therapies in B-cell lymphoma.

Download this online resource developed to serve as a helpful guide for healthcare professionals on PI3K inhibitors in B-cell lymphoma.

Download this online resource developed to serve as a helpful guide for healthcare professionals on CAR T-cell therapies in B-cell lymphoma.

Download this online resource developed to serve as a helpful guide for healthcare professionals on epigenetic therapies in B-cell lymphoma.

Download this online resource developed for healthcare professionals with a helpful guide for antibody-based therapies in B-cell lymphoma.

Download this online resource developed to serve as a helpful guide for healthcare professionals on bispecific antibodies in B-cell lymphomas.

Download this online resource developed to serve as a helpful guide for healthcare professionals on BTK inhibitors in B-cell lymphoma.

Download this online resource developed to serve as a helpful guide for healthcare professionals on immunomodulatory agents and immune checkpoint inhibitors in B-cell lymphomas.

Download this online resource developed to serve as a helpful guide for healthcare professionals on XPO1 and nuclear export inhibitors in B-cell lymphomas.

Download this online resource developed to serve as a helpful guide for healthcare professionals on antibody–drug conjugates in B-cell lymphomas.

In this podcast episode, listen to Julie M. Vose, MD, MBA; Brad S. Kahl, MD; and John P. Leonard, MD, discuss current and emerging treatment approaches for patients with B-cell lymphomas from a recent satellite symposium at the annual Hematology meeting in 2021.

Brad S. Kahl, MD John P. Leonard, MD Julie M. Vose, MD, MBA Released: February 25, 2022

In these notes from a podcast, read expert insights from Julie M. Vose, MD, MBA; Brad S. Kahl, MD; and John P. Leonard, MD, on treatment options for patients with B-cell lymphomas from a recent symposium held during the annual Hematology meeting in 2021.

Julie M. Vose, MD, MBA
Program Director Brad S. Kahl, MD John P. Leonard, MD Released: February 25, 2022